Ep. 214 Ken Shreve: Improving Portfolio Health With Medical Stocks
Investing With IBD
00:00
Dexcom's Stocks in the Diabetes Group
Dexcom is still hanging in there and fighting a, fighting a good fight. ITCI is kind of testing its 10-day moving average but it's forming an awkward looking consolidation on the weekly chart. And intracellular is another, uh, uh, non profitable biotech, but you've got triple digit revenue growth.
Play episode from 48:12
Transcript
